A low blood lymphocyte count is associated with an expansion of activated cytotoxic lymphocytes in patients with B-cell chronic lymphocytic leukaemia

European Journal of Haematology

Volumn 59, Issue 2, 1997, Pages 89-99

  Martín, Alfredo Prieto ^a   Martín, Eduardo Reyes ^a   García Suárez, Julio ^b   Arriagada, Flavio Carrión ^a   Del Puerto Hernandez Fuentes, Maria ^a   Vilaplana, Joan Cháfer ^a   Alvarez Mon Soto, Melchor ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

B chronic lymphocytic leukaemia; Blood lymphocyte count; Cytotoxic T lymphocytes; Helper lymphocytes; NK cells

Indexed keywords

CD2 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMAN; KILLER CELL; LYMPHOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030797519     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb00731.x     Document Type: Article

References (50)

1. GALTON DAG. The pathogenesis of chronic lymphocytic leukaemia. Can Med Ass J 1966: 94: 1005-1010.
2. DAMESHECK W. Chronic lymphocytic leukemia an accumulative disease of immunologically incompetent lymphocytes. Blood 1967: 29: 566-584.
3. BENNETT JM, CATOVSKY D, DANIEL MT, et al. The French-American-British (FAB) Cooperative Group proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 1989: 42: 567-584.
4. BOOGS DR, SOFFERMAN SA, WINTROBE MM, CARTWRIGHT GE. Factors influencing the duration of survival of patients with chronic lymphocytic leukemia. Am J Med 1966: 40: 243-254.
5. DAVIS S. Characterization of the phytohemagglutinin-induced proliferating lymphocyte subpopulations in chronic lymphocytic leukemia patients using a clonogenic agar technique and monoclonal antibodies. Blood 1981: 58: 1053-1055.
6. PLASTSOUCAS CD, GALINSKI M, KEMPIN S, REICH L, CLARKSON B, GOOD RA. Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies. J Immunol 1982: 129: 2305-2312.
7. LAURIA F, FOA R, MONTAVANI V, FIERRO T, CATOVSKY D, TURA S. T-cell functional abnormality in B-chronic lymphocytic leukaemia: evidence for a defect in the T-helper subset. Br J Haematol 1983: 54: 277-283.
8. KAY NE, KAPLAN ME. Defective expression of T cell antigens in chronic lymphocytic leukaemia relationship to T cell dysfunction. Br J Haematol 1984: 57: 105-111.
9. TÖTTERMAN TH, CARLSSON M, SIMONSSON B, BENGTSSON M, NILSSON K. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease. Blood 1989: 74: 786-792.
10. PRIETO A, GARCÍA-SUAREZ J, REYES E, LAPEÑA P, HERNANDEZ M, ALVAREZ-MON M. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals. Exp Hematol 1993: 21: 1563-1569.
11. ZIEGLER HW, KAY NE, ZARLING JM. Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia. Int J Cancer 1981: 27: 321-327.
12. ALVAREZ-MON M, CASAS J, LAGUNA R, JORDÁ J, DURANTEZ A. Clinical signification of natural killer activity in B-cell chronic lymphocytic leukemia. Eur J Haematol 1987: 38: 268-273.
13. HERRMAUN F, LOCHNER A, PHILIPPEN H, JAUER B, RUHL H. Imbalance of T cell subpopulations in patients with chronic lymphocytic leukemia of the B cell type. Clin Exp Immunol 1982: 49: 157-162.
14. PELLER S, KAUFMAN S. Decreased CD45RA T cells in B-cell chronic lymphatic leukemia patients: correlation with disease stage. Blood 1991: 78: 1569-1573.
15. DIANZANI U, OMEDÈ P, MARMONT F, et al. Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia: correlation with disease status and neoplastic phenotype. Blood 1994: 83: 2198-2205.
16. BRIGGS PG, KRAFT N, ATKINS RC. T-Cells and CD45RA expression in B-chronic lymphocytic leukemia. Leuk Res 1990: 14: 155-159.
17. GARCÍA-SUAREZ J, PRIETO A, REYES E, MERINO JL, ALVAREZ-MON M. Increased percentage of activated T lymphocytes in B-cell chronic lymphocytic leukaemia (B-CLL) patients. Br J Haematol 1991: 79: 657-658.
18. ALVAREZ DE MON M, CASAS J, LAGUÑA R, TORIBIO ML, DE LANDÁZURY MO, DURANTEZ A. Lymphokine induction of NK-like cytotoxicity in T cells from B-CLL. Blood 1986: 67: 228-232.
19. VUILLIER F, TORTEVOYE P, BINET JL, DIGHIERO G. CD4, CD8 and NK subsets in B-CLL. Nouv Rev Fr Hematol 1988: 30: 331-334.
20. RAI KR, SATWISKY A, CRONKITE EP, CHANA AD, LEVI RN, PASTERMACK BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975: 46: 219-234.
21. BINET JL, AUQUIER A, DIGHIERO G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981: 48: 198-206.
22. LIPSHUTZ MD, MIR R, RAI KR, SAWITSKY A. Bone marrow biopsy and clinical staging in chronic lymphocytic leukemia. Cancer 1980: 46: 1422-1428.
23. MONTSERRAT E, SÁNCHEZ-BJSOÑÓ, VIÑOLAS N, ROZMAN C. Lymphocyte doubling time in chronic lymphocytic leukemia: analysis of its prognostic significance. Br J Haematol 1986: 62: 567-575.
24. DUBNER HN, CROWLEY JJ, SCILING RF. Prognostic value of nucleoli and cell size in chronic lymphocytic leukemia. Am J Hematol 1978: 4: 337-341.
25. HAN T, HENDERSON ES, EMRICH LJ, SANDBERG AS. Prognostic significance of karyotypic abnormalities in B cell chronic lymphocytic leukemia: an update. Semin Hematol 1987: 24: 257-263.
26. ROZMAN C, MONSERRAT E, FELIU E, et al. Prognosis of chronic lymphocytic leukemia: a multivariate survival analysis of 150 cases. Blood 1982: 59: 1001-1005.
27. BACCARANI M, CAVO M, GOBBI M, LADRIA L, TURA S. Staging of chronic lymphocytic leukemia. Blood 1982: 59: 1191-1196.
28. MONTSERRAT E, VIÑOLAS L, REVERTER JC, ROZMAN C. Natural history of chronic leukemia: on the progression and prognosis of early clinical stages. Nouv Rev Fr Haematol 1988: 30: 359-361.
29. FRENCH CO-OPERATIVE GROUP ON CHRONIC LYMPHOCYTIC LEUKAEMIA. Natural history of stage A chronic lymphocytic leukaemia untreated patients. Br J Haematol 1990: 76: 45-57.
30. MANASTER J, FRUHLING J, STRICKMANS P. Kinetics of lymphocytes in chronic lymphocytic leukemia. 1. Equilibrium between blood and "readily accessible pool". Blood 1973: 41: 425-438.
31. STRYCKMANS PA, DEBUSSCHER L, COLLARD E. Cell kinetics in chronic lymphocytic leukemia (CLL). Clin Haematol 1977: 6: 159-168.
32. OLD LJ. Cancer immunology: the search for specificity. Cancer Res 1981: 41: 361-375.
33. GRIMM EA, MAZUNDER A, ZHANG HZ, ROSEMBERG SA. Lymphokine-activated killer cell phenomenon. Lysis of natural killer resistant fresh solid tumour cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1989: 155: 1823-1841.
34. DADMARZ R, RABINOWE SN, CANNISTRA SA, ANDERSEN JW, FREEDMAN AS, NADLER LM. Association between clonogenic cell growth and clinical risk group in B-cell chronic lymphocytic leukemia. Blood 1990: 76: 142-149.
35. INTERNATIONAL WORKSHOP ON CHRONIC LYMPHOCYTIC LEUKEMIA. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med 1989: 110: 236-238.
36. BÖYUM AJ. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968: 21: 77-89.
37. MADSEN M, JOHNSEN HE, HANSEN PW, CHRISTIANSEN SE. Isolation of human T and B lymphocytes by E-rosette gradient centrifugation: characterization of the isolated sub-populations. J Immunol Meth 1980: 33: 323-336.
38. PARNES JR. Molecular biology and function of CD4 and CD8. Adv Immunol 1989: 44: 265-311.
39. +CD57 hybridoma. Immunology 1993: 78: 205-209.
40. SANDERS ME, MAKGOBA MW, SHAW S. Human naive and memory T cells. Immunol Today 1988: 9: 195-199.
41. WEN T, MELLSTEDT H, JONDAL M. Presence of clonal T cell populations in chronic B lymphocytic leukemia and smouldering myeloma. J Exp Med 1990: 171: 659-666.
42. FARACE F, ORLANDUCCI F, DIETRICH PY, et al. T cell repertoire in patients with B chronic lymphocytic leukemia: evidence for multiple in vivo T cell clonal expansions. J Immunol 1994: 153: 4281-4290.
43. OTA K. Antigen presentation by T cells and inducing anergy. Nippon Rinsho 1994: 52: 2811-2816.
44. + T cells that induces contact-dependent B cell differentiation (help). J Exp Med 1992: 175: 1091-1101.
45. LEDERMAN S, YELLIN MJ, CLEARY AM, et al. T-BAM/CD40-L on helper T lymphocytes augments lymphokine induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol 1994: 152: 2163-2171.
46. FLUCKIGER AC, ROSSI JF, BUSSEL A, BRYON P, BANCHEREAU J, DEFRANCE T. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 1992: 80: 3173-3181.
47. EHLERS S, KENDALL AS. Differentiation of T cell lymphokine gene expression: the in vitro aquisition of T cell memory. J Exp Med 1991: 173: 25-36.
48. BUSCHLE M, CAMPANA D, CARDING SR, RICHARD C, HOFFBRAND AV, BRENNER MK. IFN-gamma inhibits programmed cell death and promotes survival of B-CLL cells in culture. J Exp Med 1993: 177: 213-218.
49. AGUILAR-SANTESLISES M, LOFTENIUS A, LJUNGH C, et al. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis. Leuk Res 1992: 16: 607-613.
50. AGUILAR-SANTESLISES M, MELLSTEDT H, JONDAL M. Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro. Leukemia 1994: 8 1146-1152.